AVBP

ArriVent BioPharma, Inc.

Contracts

Total Value

Stock Metrics

27.0%

Short % Float

13.9d to cover · High squeeze

98.9%

Inst % Float

10 holders · 2026-06-30

Suvretta Capital M

Top Holder

9.4% of float

29.8M sh

Public Float

35/100

Dilution Score

Medium

27 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

35/100

MEDIUM

Inst: 98.88% · Top: Suvretta Capital Management, LLC

Biotech Analytics

Biotech / Pharma

52.96

Squeeze risk: HIGH

Insider Buying0

Publications100

Dilution Risk35

Clinical Trials88

Short Interest70